Literature DB >> 17940204

t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).

Lisa J Russell1, Takashi Akasaka, Aneela Majid, Kei-Ji Sugimoto, E Loraine Karran, Inga Nagel, Lana Harder, Alexander Claviez, Stefan Gesk, Anthony V Moorman, Fiona Ross, Helen Mazzullo, Jonathan C Strefford, Reiner Siebert, Martin J S Dyer, Christine J Harrison.   

Abstract

Translocations involving the immunoglobulin heavy chain locus (IGH@) at chromosome band 14q32 are common in mature B-cell neoplasms, but are rare in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here, we report the translocation, t(6;14)(p22;q32), involving IGH@ as a novel recurrent translocation in 13 BCP-ALL patients. Fluorescence in situ hybridization and long-distance inverse polymerase chain reaction (PCR) identified ID4 as the partner gene. Breakpoints were scattered over a 19kb region centromeric of ID4. Quantitative real-time PCR showed up-regulation of ID4 mRNA. All patients had deletions of CDKN2A and PAX5 located on the short arm of chromosome 9, frequently as a result of an isochromosome, i(9)(q10) (9/13, 69%). This study defines a new subgroup of BCP-ALL characterized by ID4 over-expression and CDKN2A and PAX5 deletions. Preliminary survival data suggest that this subgroup may be associated with a good response to therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940204     DOI: 10.1182/blood-2007-07-092015

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.

Authors:  Jan Harder; Michael J Müller; Matthias Fuchs; Vera Gumpp; Annette Schmitt-Graeff; Richard Fischer; Melanie Frank; Oliver Opitz; Jens Hasskarl
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  IGH@ translocations co-exist with other primary rearrangements in B-cell precursor acute lymphoblastic leukemia.

Authors:  Sally J Jeffries; Lisa Jones; Christine J Harrison; Lisa J Russell
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

3.  A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia.

Authors:  Moneeb A K Othman; Beata Grygalewicz; Barbara Pienkowska-Grela; Jolanta Rygier; Anna Ejduk; Martina Rincic; Joana B Melo; Isabel M Carreira; Britta Meyer; Thomas Liehr
Journal:  Oncol Lett       Date:  2016-01-29       Impact factor: 2.967

4.  Role of heteroplasmic mutations in the mitochondrial genome and the ID4 gene promoter methylation region in the pathogenesis of chronic aplastic anemia in patients suffering from Kidney yin deficiency.

Authors:  Xing Cui; Jing-Yi Wang; Kui Liu; Si-Yuan Cui; Jie Zhang; Ya-Qin Luo; Xin Wang
Journal:  Chin J Integr Med       Date:  2015-04-29       Impact factor: 1.978

Review 5.  The role of Pax5 in leukemia: diagnosis and prognosis significance.

Authors:  Mohammad Shahjahani; Fatemeh Norozi; Ahmad Ahmadzadeh; Saeid Shahrabi; Farzaneh Tavakoli; Ali Amin Asnafi; Najmaldin Saki
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

6.  Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer.

Authors:  James V Tricoli; Nita L Seibel; Donald G Blair; Karen Albritton; Brandon Hayes-Lattin
Journal:  J Natl Cancer Inst       Date:  2011-03-24       Impact factor: 13.506

7.  Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

Authors:  Akinori Yoda; Yuka Yoda; Sabina Chiaretti; Michal Bar-Natan; Kartik Mani; Scott J Rodig; Nathan West; Yun Xiao; Jennifer R Brown; Constantine Mitsiades; Martin Sattler; Jeffrey L Kutok; Daniel J DeAngelo; Martha Wadleigh; Alfonso Piciocchi; Paola Dal Cin; James E Bradner; James D Griffin; Kenneth C Anderson; Richard M Stone; Jerome Ritz; Robin Foà; Jon C Aster; David A Frank; David M Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

8.  A rare case of acute lymphoblastic leukemia in a patient with light chain (AL) amyloidosis treated with lenalidomide.

Authors:  Ranjit Nair; Shereen Gheith; Dan Popescu; Nicole M Agostino
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Authors:  Jason P W Carey; Ananthi J Asirvatham; Oliver Galm; Tandeih A Ghogomu; Jaideep Chaudhary
Journal:  BMC Cancer       Date:  2009-06-07       Impact factor: 4.430

10.  Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells.

Authors:  Carolin Manthey; Demissew S Mern; Anja Gutmann; Anne J Zielinski; Corinna Herz; Silke Lassmann; Jens Hasskarl
Journal:  BMC Cell Biol       Date:  2010-01-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.